Cystetic Medicines
Cambridge, United States· Est.
Focuses on developing novel therapies for cystic fibrosis and other genetic diseases using advanced molecular approaches.
Private Company
Total funding raised: $10M
About
Focuses on developing novel therapies for cystic fibrosis and other genetic diseases using advanced molecular approaches.
Small Molecules
Funding History
1Total raised:$10M
Seed$10M